Plasminogen activator inhibitor in human tears after laser refractive surgery

Journal of Cataract and Refractive Surgery

Volumn 34, Issue 6, 2008, Pages 897-901

  Csutak, Adrienne ^a   Silver, David M ^a   Tozsér, József ^a   Steiber, Zita ^a   Bagossi, Peter ^a   Hassan, Ziad ^a   Berta, András ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; FLUOROMETHOLONE; HYDROXYPROPYLMETHYLCELLULOSE; PLASMINOGEN ACTIVATOR INHIBITOR; TEARS NATURALE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA OPACITY; DRUG DOSE TITRATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; HUMAN; KERATOMILEUSIS; LACRIMAL FLUID; LASER SURGERY; PHOTOREFRACTIVE KERATECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; REFRACTIVE SURGERY; SURGICAL WOUND; UNIVERSITY HOSPITAL;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; HUMANS; KERATOMILEUSIS, LASER IN SITU; MYOPIA; PHOTOREFRACTIVE KERATECTOMY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; POSTOPERATIVE PERIOD; TEARS; WOUND HEALING;

EID: 43949129415     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2008.02.024     Document Type: Article

References (24)

1. Pop M., and Payette Y. Photorefractive keratectomy versus laser in situ keratomileusis; a control-matched study. Ophthalmology 107 (2000) 251-257
2. Farah S.G., Azar D.T., Gurdal C., and Wong J. Laser in situ keratomileusis: literature review of a developing technique. J Cataract Refract Surg 24 (1998) 989-1006
3. Rajan M.S., Jaycock P., O'Brart D., Ham Nystrom H., and Marshall J. A long-term study of photorefractive keratectomy; 12-year follow-up. Ophthalmology 111 (2004) 1813-1824
4. Chan T.K., Ashraf M.F., and Azar D.T. Photorefractive keratectomy (PRK) outcomes and complications. In: Azar D.T., Steinert R.F., and Stark W.J. (Eds). Excimer Laser Phototherapeutic Keratectomy (1997), Williams & Wilkins, Baltimore, MD 157-173
5. Hadden O.B., Ring C.P., Morris A.T., and Elder M.J. Visual, refractive, and subjective outcomes after photorefractive keratectomy for myopia of 6 to 10 diopters using the Nidek laser. J Cataract Refract Surg 25 (1999) 936-942
6. Mayer M. Biochemical and biological aspects of the plasminogen activation system. Clin Biochem 23 (1990) 197-211
7. Hayashi K., and Sueishi K. Fibrinolytic activity and species of plasminogen activator in human tears. Exp Eye Res 46 (1988) 131-137
8. Wang H.-M., Berman M., and Law M. Latent and active plasminogen activator in corneal ulceration. Invest Ophthalmol Vis Sci 26 (1985) 511-524. http://www.iovs.org/cgi/reprint/26/4/511 Accessed March 11, 2008
9. Csutak A., To{combining double acute accent}zsér J., Békési L., Hassan Z., Berta A., and Silver D.M. Plasminogen activator activity in tears after excimer laser photorefractive keratectomy. Invest Ophthalmol Vis Sci 41 (2000) 3743-3747. http://www.iovs.org/cgi/reprint/41/12/3743 Accessed March 11, 2008
10. Grøndahl-Hansen J., Lund L.R., Ralfkiaer E., Ottevanger V., and Danø K. Urokinase- and tissue-type plasminogen activators in keratinocytes during wound re-epithelialization in vivo. J Invest Dermatol 90 (1988) 790-795. http://www.nature.com/jid/journal/v90/n6/pdf/5613632a.pdf Accessed March 11, 2008
11. Schäfer B.M., Marier K., Eickhoff U., Todd R.F., and Kramer M.D. Plasminogen activation in healing human wounds. Am J Pathol 144 (1994) 1269-1280. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1887462&blobty pe=pdf Accessed March 11, 2008
12. Csutak A., Silver D.M., To{combining double acute accent}zsér J., Facskó A., and Berta A. Plasminogen activator activity and inhibition in rabbit tears after photorefractive keratectomy. Exp Eye Res 77 (2003) 675-680
13. Lohmann C.P., and Marshall J. Plasmin- and plasminogen-activator inhibitors after excimer laser photorefractive keratectomy: new concept in prevention of postoperative myopic regression and haze. Refract Corneal Surg 9 (1993) 300-302
14. O'Brart D.P.S., Lohmann C.P., Klonos G., Corbett M.C., Pollock W.S.T., Kerr-Muir M.G., and Marshall J. The effects of topical corticosteroids and plasmin inhibitors on refractive outcome, haze, and visual performance after photorefractive keratectomy; a prospective, randomized, observer-masked study. Ophthalmology 101 (1994) 1565-1574
15. Tervo T., Tervo K., van Setten G.-B., Virtanen I., and Tarkkanen A. Plasminogen activator and its inhibitor in the experimental corneal wound. Exp Eye Res 48 (1989) 445-449
16. Tözsér J., and Berta A. Plasminogen activator inhibitors in human tears. Acta Ophthalmol (Copenh) 69 (1991) 426-431
17. Williams D.L., Risse B., Kim S., Saunders D., Orlin S., Baker M.S., Jensen P.J., and Lavker R.M. Plasminogen activator inhibitor type 2 in human corneal epithelium. Invest Ophthalmol Vis Sci 40 (1999) 1669-1675. http://www.iovs.org/cgi/reprint/40/8/1669 Accessed March 11, 2008
18. Hanna K.D., Pouliquen Y.M., Savoldelli M., Fantes F., Thompson K.P., Waring III G.O., and Samson J. Corneal wound healing in monkeys 18 months after excimer laser photorefractive keratectomy. Refract Corneal Surg 6 (1990) 340-345
19. van Haeringen N.J., and Glasius E. The origin of some enzymes in tear fluid, determined by comparative investigation with two collection methods. Exp Eye Res 22 (1976) 267-272
20. Weimar V. Polymorphonuclear invasion of wounded corneas; inhibition by topically applied sodium salicylate and soybean trypsin inhibitor. J Exp Med 105 (1957) 141-152. http://www.jem.org/cgi/reprint/105/2/141 Accessed March 11, 2008
21. Blasi F. uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways?. Immunol Today 18 (1997) 415-417
22. Hayashi K., Berman M., Smith D., El-Ghatit A., Pease S., and Kenyon K.R. Pathogenesis of corneal epithelial defects: role of plasminogen activator. Curr Eye Res 10 (1991) 381-398
23. Møller-Pedersen T., Li H.F., Petroll W.M., Cavanagh H.D., and Jester J.V. Confocal microscopic characterization of wound repair after photorefractive keratectomy. Invest Ophthalmol Vis Sci 39 (1998) 487-501. http://www.iovs.org/cgi/reprint/39/3/487 Accessed March 11, 2008
24. Csutak A., Silver D.M., To{combining double acute accent}zsér J., Hassan Z., and Berta A. Urokinase-type plasminogen activator to prevent haze after photorefractive keratectomy, and pregnancy as a risk factor for haze in rabbits. Invest Ophthalmol Vis Sci 45 (2004) 1329-1333. http://www.iovs.org/cgi/reprint/45/5/1329 Accessed March 11, 2008